SB 202190, CAS 152121-30-7

Description: SB 202190 (FHPI) is a p38 MAPK inhibitor that inhibits p38α and p38β2 (IC50=50/100 nM) selectively and cell-permeably. SB 202190 has antitumor activity and also induces the differentiation of human embryonic stem cells into cardiomyocytes.

CAS Number: 152121-30-7

Formula: C20H14FN3O

Molecular Weight: 331,34

References: Nassar K, et al. A p38 MAPK inhibitor improves outcome after glaucoma filtration surgery. J Glaucoma. 2015 Feb;24(2):165-78.

• Artikelnummer: TGMT2301-100mg
• Hersteller: TargetMol Chemicals
• Hersteller Artikelnummer: T2301-100mg
• Verpackungseinheit: 100 mg
• Mengeneinheit: STK